XK
BMY icon

Xact Kapitalforvaltning’s Bristol-Myers Squibb BMY Stock Holding History

Xact Kapitalforvaltning’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$29.2M Buy
523,396
+163,194
+45% +$9.97M 0.62% 31
2019
Q4 		$23.1M Buy
360,202
+8,988
+3% +$515K 0.39% 49
2019
Q3 		$17.8M Buy
351,214
+29,276
+9% +$1.38M 0.34% 58
2019
Q2 		$14.6M Buy
321,938
+19,304
+6% +$899K 0.3% 63
2019
Q1 		$14.4M Buy
302,634
+7,043
+2% +$351K 0.33% 57
2018
Q4 		$15.4M Sell
295,591
-11,244
-4% -$604K 0.39% 49
2018
Q3 		$19M Sell
306,835
-24,375
-7% -$1.45M 0.4% 46
2018
Q2 		$18.3M Buy
331,210
+11,384
+4% +$615K 0.39% 46
2018
Q1 		$20.2M Buy
319,826
+11,865
+4% +$763K 0.46% 38
2017
Q4 		$18.9M Buy
307,961
+19,298
+7% +$1.21M 0.45% 39
2017
Q3 		$18.4M Buy
288,663
+2,238
+0.8% +$131K 0.53% 38
2017
Q2 		$16M Buy
286,425
+9,310
+3% +$507K 0.48% 38
2017
Q1 		$15.1M Buy
277,115
+11,732
+4% +$643K 0.46% 43
2016
Q4 		$15.5M Buy
265,383
+14,099
+6% +$771K 0.54% 37
2016
Q3 		$13.5M Buy
+251,284
New +$16.1M 0.48% 43

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Xact Kapitalforvaltning's BMY Position: Q1 2020 in Review

Xact Kapitalforvaltning increased its Bristol-Myers Squibb (BMY) stake by 45% in Q1 2020, buying an estimated $9.97M and bringing the position to 523,396 shares worth $29.2M. The position accounts for 0.62% of the portfolio, ranked #31.

Xact Kapitalforvaltning first reported a position in BMY in Q3 2016 and has held it in 15 quarters since. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Xact Kapitalforvaltning held 523,396 shares of Bristol-Myers Squibb worth $29.2M as of Q1 2020.
  • Xact Kapitalforvaltning bought 163,194 Bristol-Myers Squibb shares in Q1 2020, an estimated $9.97M.
  • Bristol-Myers Squibb made up 0.62% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #31 holding.
  • Xact Kapitalforvaltning first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 15 quarters since.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.